Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-25 @ 5:08 AM
NCT ID: NCT01466127
Eligibility Criteria: Inclusion Criteria: * Men or women 18 to 65 years of age * Score in study range on the Neuroticism-Extraversion-Openness-Five Factor Inventory (NEO-FFI) * No current Axis I Diagnostic and Statistical Manual-IV (DSM) excluded diagnoses as determined by the Structured Clinical Interview DSM (SCID) completed within the past 4 months. * Must be able and willing to understand study procedures and return to the clinic on two separate consecutive days for the fear-conditioning procedures. * Subjects must be able to give informed consent and be willing and able to comply with study procedures. Exclusion Criteria: * Presence of a current DSM-IV Axis I diagnosis as measured by the SCID. * A serious medical condition or other condition deemed likely to result in surgery or hospitalization, or which would make participation in the study difficult. * Patients with a history of trauma resulting in head injury related seizures or with epilepsy (except a prior history of febrile seizures of infancy which are not exclusionary). * Use of supplemental hormones (birth control, estrogen, testosterone, prednisone, etc) or narcotics. * Pregnant or lactating women. * Women of childbearing potential not using medically accepted forms of contraception. * Current use of the excluded psychiatric medications. * Known hypersensitivity to oxytocin * Known hyponatremia.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT01466127
Study Brief:
Protocol Section: NCT01466127